Leo Pharma SA
21.7 FTEThe score of Leo Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue +19 % Equity +27 % Total assets -21 % Headcount (avg FTE) -34 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Leo Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 06 May 2026
- Year ended 31 Dec 2024filed on 23 Jun 2025
- Year ended 31 Dec 2023filed on 21 May 2024
- Year ended 31 Dec 2022filed on 05 Jun 2023
- Year ended 31 Dec 2021filed on 28 Jul 2022
Leo Pharma's financial analysis
- Solvency66.0%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Leo Pharma
Leo Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0404.780.604
- VAT number
- BE0404780604
- Peppol
- Registered · 0208:0404780604 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 01 Apr 1967
- Registered office
- 2500 Lier
- Size
- Small · 21.7 FTE
- Latest accounts
- 2025 · filed on 06 May 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Leo Pharma (SA) has been based in Lier since 1967, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports revenue of €32.1m, a net profit of 615,360 € and equity of €9.93m. With 21.7 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 66.0%, above the median of its sector (46.0%).
Companies similar to Leo Pharma
Companies in the same business, of comparable size and area, outside its group.
- DE Ceunynck Medical Wholesale of pharmaceutical and medical goods Aartselaar · balance sheet €16.9m
- Teva Pharma Belgium Wholesale of pharmaceutical and medical goods Antwerp · balance sheet €33.4m
- Valerco Wholesale of pharmaceutical and medical goods Kontich · balance sheet €12.9m
- Elekta Wholesale of pharmaceutical and medical goods Zaventem · balance sheet €13.1m
- MED Concept Europe Wholesale of pharmaceutical and medical goods Woluwe-Saint-Pierre · balance sheet €18.7m
- Coloplast Belgium Wholesale of pharmaceutical and medical goods Beersel · balance sheet €16.8m
- Recordati Wholesale of pharmaceutical and medical goods Jette · balance sheet €20.8m
- Merck Wholesale of pharmaceutical and medical goods Hoeilaart · balance sheet €26.6m
Frequently asked questions about Leo Pharma
What is the revenue of Leo Pharma?
According to the 2025 annual accounts filed with the NBB, the revenue of Leo Pharma amounts to 32,071,831 €.
What is the VAT number of Leo Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0404780604 for Leo Pharma, if the company is VAT-registered. Its company number (CBE) is 0404.780.604.
Where is the registered office of Leo Pharma?
According to the CBE register, the registered office of Leo Pharma is in 2500 Lier.
What is the equity of Leo Pharma?
At the close of the 2025 financial year, the equity of Leo Pharma amounts to 9,934,463 €, a solvency of 66.0% of total assets.
How many people work at Leo Pharma?
21.7 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Leo Pharma?
The register lists 3 active mandates at Leo Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Leo Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →